Skip to main content
logo
Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
19.53
-0.01 (-0.05%)
Nov 2, 2026, 4:00 PM EST - Market closed

Odyssey Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
936----
Market Cap Growth
-----
Enterprise Value
528----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.060.130.230.150.17
Net Debt / Equity Ratio
-0.97-0.88-0.74-0.81-0.81
Net Debt / EBITDA Ratio
2.721.260.761.411.67
Net Debt / FCF Ratio
3.081.450.831.541.77
Asset Turnover
-0.010.020.00-
Quick Ratio
10.986.854.558.4710.57
Current Ratio
11.367.204.778.7210.91
Return on Equity (ROE)
--85.50%-72.26%-53.29%-
Return on Assets (ROA)
--41.66%-34.93%-27.63%-
Return on Capital Employed (ROCE)
-34.00%-64.00%-80.00%-50.50%-41.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Buyback Yield / Dilution
-1383.37%-267.45%-24.54%-44.71%-
SEC Filings: 10-K · 10-Q